Search This Blog

Tuesday, August 6, 2019

Allergan EPS beats by $0.04, beats on revenue

Allergan (NYSE:AGN): Q2 Non-GAAP EPS of $4.38 beats by $0.04; GAAP EPS of -$5.37 misses by $5.93.
Revenue of $4.09B (-0.7% Y/Y) beats by $160M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)